Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Israeli Science Foundation
Grant: 3711/20
Israel Science Foundation
Grant: 41222/18
Israeli Innovation Authority
Grant: 68972
National Institutes of Health
Grant: HL124209
BSF
Grant: 2017176
Burroughs Welcome Fund
Grant: Career Award for Medical Scientists
National Institutes of Health
Grant: 7R01HL124209-06
Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesis
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes
Additional file 1 of Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes